Intermediates

Spiro[1-azabicyclo[2.2.2]octane-3,2'-oxirane]

  • CAS No.41353-91-7
  • GradeIndustrial / Pharmaceutical
  • Availability● In Stock

High-purity Spiro[1-azabicyclo[2.2.2]octane-3,2'-oxirane] (CAS 41353-91-7) designed for pharmaceutical synthesis. Ideal intermediate for Cevimeline production with ≥98.0% assay.

Request Bulk Pricing

Product Technical Details

Product Overview

Spiro[1-azabicyclo[2.2.2]octane-3,2'-oxirane] is a highly specialized organic compound recognized for its critical role in modern medicinal chemistry. Identified by CAS number 41353-91-7, this substance features a unique spiro-connected bicyclic structure incorporating an oxirane ring. This specific configuration provides exceptional reactivity profiles suitable for complex synthetic pathways. Our facility produces this intermediate under strict quality control protocols to ensure consistency and reliability for downstream pharmaceutical manufacturing processes.

The molecular architecture of this compound allows for precise functionalization, making it an indispensable building block in the synthesis of therapeutic agents. As a key precursor, it supports the production of high-value active pharmaceutical ingredients (APIs) where structural integrity and purity are paramount. We understand the rigorous demands of the pharmaceutical industry and deliver products that meet exacting specifications.

Technical Specifications

Our manufacturing process ensures that every batch adheres to comprehensive physical and chemical standards. The following table outlines the critical parameters verified during quality assurance testing.

ParameterSpecification
CAS Number41353-91-7
Molecular FormulaC8H13NO
Molecular Weight139.195
AppearanceYellow to brown liquid
Assay≥98.0%
Density1.2±0.1 g/cm3
Boiling Point211.3±13.0 °C at 760 mmHg
Flash Point60.4±22.2 °C
Refractive Index1.564

Pharmaceutical Applications

This intermediate is primarily utilized in the synthesis of Cevimeline and its hydrochloride salt. Cevimeline is a muscarinic agonist employed in the treatment of symptoms associated with Sjogren's syndrome, specifically xerostomia (dry mouth). The epoxide functionality within the spiro[1-azabicyclo[2.2.2]octane] framework enables specific ring-opening reactions necessary for constructing the final active molecule. Precision in this stage of synthesis is crucial to minimize impurities and maximize yield in the final drug product.

Beyond its primary application, this chemical serves as a valuable tool in research and development for novel neurological therapeutics. The quinuclidine backbone is a privileged structure in drug design, offering favorable pharmacokinetic properties. Our clients leverage this intermediate to explore new chemical entities with potential therapeutic benefits in various disease states requiring cholinergic modulation.

Quality Assurance and Manufacturing

We operate as a global manufacturer committed to delivering industrial purity levels. Each production run undergoes rigorous analytical testing using advanced chromatography and spectroscopy methods. We provide a Certificate of Analysis (COA) with every shipment, detailing batch-specific data to ensure full traceability. Our supply chain is optimized for reliability, ensuring that bulk orders are fulfilled promptly without compromising on quality standards.

Storage and Handling

To maintain chemical stability, Spiro[1-azabicyclo[2.2.2]octane-3,2'-oxirane] should be stored in a cool, ventilated place away from direct sunlight and moisture. The container must remain tightly sealed when not in use to prevent degradation. Standard safety precautions for handling organic epoxides should be followed, including the use of appropriate personal protective equipment. We offer flexible packaging options, including 200 kg drums, or custom solutions tailored to specific logistical requirements.